ライフサイエンスコーパス: bone marrow aspirate

1 ears of diagnosis who had detectable DTCs on bone marrow aspirate.

2 for microscopic analysis of blood smears and bone marrow aspirates.

3 MS) was tested on four human and four canine bone marrow aspirates.

4 gely dependent on morphologic examination of bone marrow aspirates.

5 al cytokeratin assay in preoperatively taken bone marrow aspirates.

6 arget lymphoma cells mixed with normal human bone marrow aspirates.

7 upport cells that can be easily derived from bone marrow aspirates.

8 sites or their DNA in spleen, lymph node, or bone marrow aspirates.

9 s, has been applied to the in vitro study of bone marrow aspirates.

10 to analyze peripheral-blood lymphocytes and bone marrow aspirates.

11 erwent rigorous staging as defined by both a bone marrow aspirate and biopsy and an imaging study (a

12 Bone marrow aspirate and biopsy and bone scan are unnece

13 Bone marrow aspirate and biopsy specimens were studied,

14 A bone marrow aspirate and peripheral blood were obtained

15 OEMS; therefore, peripheral blood smears and bone marrow aspirates and biopsies from 87 patients (143

16 We reviewed bone marrow aspirates and biopsies, quantified blood/mar

17 arget leukemia cells mixed with normal human bone marrow aspirates and can also identify cancer cells

18 arance of lymphoblasts from day 7 and day 14 bone marrow aspirates and more prolonged asparaginase ac

19 Using mouse and human bone marrow aspirates and mouse models challenged with h

20 w) and cellular immune assays of iliac crest bone marrow aspirates and peripheral blood have begun to

21 Bone marrow aspirates and peripheral blood were obtained

22 Primary human MSC were cultured from bone marrow aspirates and then passaged at least three t

23 were isolated from white adipose tissue and bone marrow aspirates and were s.c. implanted into immun

24 the peripheral blood and <1000 copies in the bone marrow aspirate), and high levels of MRD had an est

25 ht microscopy by 10-fold in samples of fresh bone marrow aspirate approximating minimal residual dise

26 We collected bone marrow aspirates, archival bone marrow samples, and

27 R-Flow measurements of recipient iliac crest bone marrow aspirates as in previous studies on peripher

28 MRD was assessed from first-pull bone marrow aspirates at baseline and annually by flow c

29 PL in blood films (AUC 0.94 +/- 0.04) and in bone marrow aspirates (AUC 0.99 +/- 0.01).

30 metric flow cytometry (MFC) was performed on bone marrow aspirates before HCT.

31 expression and chromatin landscape of human bone marrow, aspirated before and 90 days after BCG vacc

32 Peripheral-blood (PB) and/or bone marrow aspirate (BM) samples were obtained from 28

33 udy of PC obtained prospectively from random bone marrow aspirates (BM) and paired imaging-guided bio

34 Cytomorphological analysis of the bone marrow aspirate (BMA) is pivotal for the diagnostic

35 cal microscopy inspection of blood films and bone marrow aspirates by a hematologist is a crucial ste

36 In primary myeloma cells derived from bone marrow aspirates, CD46-ADC induced apoptosis and ce

37 Bone marrow aspirate concentrate (BMAC) and adipose-deri

38 ngineered ACL matrix by supplementation with bone marrow aspirate concentrate (BMAC) and growth facto

39 id evaluation of a subset of patient-derived bone marrow aspirate concentrate (BMAC) samples used in

40 Arm 1: autologous bone marrow aspirate concentrate (n = 120), CSI (n = 40)

41 therapies (such as platelet-rich plasma and bone marrow aspirate concentrate) is common, high-qualit

42 efficacy of cell injections from autologous bone marrow aspirate concentrate, autologous adipose str

43 Moreover, iliac crest bone marrow aspirates contained an average of thirteen t

44 mal and mesenchymal cells derived from human bone marrow aspirates express the cell-bound form of fra

45 ripheral blood mononuclear cells (PBMCs) and bone marrow aspirates for regulatory T cells (Tregs) (e.

46 noglobulin FISH done on cytospin slides from bone marrow aspirates for t(11;14), t(4;14), and -17(p13

47 otyping, to identify mutations in samples of bone marrow aspirate from 439 patients with myelodysplas

48 ted from a mean +/- SD of 23.4 +/- 5.9 mL of bone marrow aspirate from all patients.

49 es, positivity for MMc was demonstrated in a bone marrow aspirate from an SSc patient in whom periphe

50 We obtained bone marrow aspirates from 11 patients on ART who had un

51 the frequency of S-specific plasma cells in bone marrow aspirates from 18 individuals who had recove

52 agasi, cytokine mRNA levels were measured in bone marrow aspirates from 27 naturally infected dogs fr

53 Here, we analyzed bone marrow aspirates from 44 advanced prostate cancer p

54 ation (ISH) for IL-1beta was performed using bone marrow aspirates from 51 MM, 7 smoldering MM, 21 MG

55 Despite the peripheral neutropenia, bone marrow aspirates from affected individuals contain

56 the presence of disseminated tumor cells in bone marrow aspirates from early stage breast cancer pat

57 in vitro differentiated CD34 cells and from bone marrow aspirates from Fy-negative samples express a

58 technique, we analyzed peripheral blood and bone marrow aspirates from human clinical samples, and i

59 in latency, these transcripts are present in bone marrow aspirates from naturally infected, healthy s

60 is procedure, the extent of demethylation in bone marrow aspirates from patients with leukemia receiv

61 Bone marrow aspirates from the patient showed <0.1% CD19

62 submicroscopic levels of leukaemic cells in bone-marrow aspirates from children with acute lymphobla

63 Repeated analyses of blood and bone marrow aspirates gave no indication of hematopoieti

64 omarker for magnetic separation of CTPs from bone marrow aspirates in a canine model.

65 d 10-color multiparametric flow cytometry on bone marrow aspirates in all patients.

66 Bone marrow aspirates in two patients had markedly decre

67 d genotyping to profile 38,410 cells from 40 bone marrow aspirates, including 16 AML patients and fiv

68 Potential admixture of blood with bone marrow aspirate limits our ability to determine the

69 struction of transplantable tissues in which bone marrow aspirates may serve as an accessible source

70 andomized to receive autologous concentrated bone marrow aspirate (n = 10; 3 x 10(6) white blood cell

71 Bone marrow aspirates (n = 629) were collected at the en

72 Ten normal bone marrow aspirates (NBM) were first analyzed using an

73 One bone marrow aspirate obtained before treatment, one whol

74 A-1)/CD70 in the CD10(+)/CD19(+) fraction of bone marrow aspirates obtained from relapsed compared wi

75 MSCs were prepared from bone marrow aspirates obtained from the iliac crest or f

76 Single-cell RNA-sequencing performed in bone marrow aspirates of 11 MM patients and 8 healthy do

77 oma cells isolated by CD138 sorting from the bone marrow aspirates of 6 patients.

78 High levels of serglycin are present in the bone marrow aspirates of at least 30% of newly diagnosed

79 Moreover, cells isolated from bone marrow aspirates of patients in different stages of

80 (10-20) that can typically be obtained from bone marrow aspirates of prostate-cancer patients.

81 equencies of mature B cells were observed in bone marrow aspirates of these individuals compared with

82 e detected by a rapid immunological assay in bone-marrow aspirates of children with ALL.

83 mor burden cohorts (HTBC or LTBC) based on a bone marrow aspirate or biopsy before infusion.

84 ion of hematopoietic stem cells from a human bone marrow aspirate possessing only 4000 total cells.

85 fluence of platelet-rich plasma derived from bone marrow aspirate (PRP-BMA) on the healing of periodo

86 e by testing of whole blood, buffy coat, and bone marrow aspirates, respectively.

87 Cytologic analysis of bone marrow aspirates revealed a striking enhancement of

88 w common VEXAS syndrome is in patients whose bone marrow aspirates show this distinctive feature, fin

89 cal details of the individual cases reviewed bone marrow aspirate slides to determine plasmablastic c

90 Bone marrow aspirate smears and biopsies may show reacti

91 Blood and bone marrow aspirate testosterone concentrations decline

92 ession >/= 10% was correlated with increased bone marrow aspirate testosterone.

93 with uncomplicated typhoid and satisfactory bone marrow aspirates, the number of serovar Typhi CFU i

94 uppression of testosterone in both blood and bone marrow aspirate to less than picograms-per-millilit

95 ls obtained from peripheral blood or through bone marrow aspirates, together with recent advances in

96 uencing (WGS) was performed on the patient's bone marrow aspirate, using an Illumina NextSeq500 platf

97 A small bone marrow aspirate was taken from the iliac crest of h

98 spirates, the number of serovar Typhi CFU in bone marrow aspirates was a median value of 9 (interquar

99 ody production by CD138+ cells enriched from bone marrow aspirates was abrogated.

100 of autologous granulocytic progenitors from bone marrow aspirate were performed in two patients with

101 Bone marrow aspirates were analyzed for their neutrophil

102 Blood and bone marrow aspirates were obtained from 4 patients (2 u

103 Bone marrow aspirates were performed at baseline for exp

104 Bone marrow aspirates were stained with the pancytokerat

105 Bone marrow aspirates were subject to a negative-selecti

106 Bone-marrow aspirates were collected after induction the

107 ncentrations of PDGF-AA and PDGF-BB found in bone marrow aspirates, which were detected by ELISA, do

108 A bone-marrow aspirate with biopsy was performed, yielding